ijms-logo

Journal Browser

Journal Browser

Computational Approaches in Drug Design: Novel Methodologies and Applications

A special issue of International Journal of Molecular Sciences (ISSN 1422-0067). This special issue belongs to the section "Molecular Informatics".

Deadline for manuscript submissions: 30 November 2024 | Viewed by 739

Special Issue Editor


E-Mail Website
Guest Editor
Department of Pharmaceutical Sciences, Università degli Studi di Milano, via Mangiagalli 25, 20133 Milano, Italy
Interests: medicinal chemistry; drug discovery; enzyme inhibitors
Special Issues, Collections and Topics in MDPI journals

Special Issue Information

Dear Colleagues,

Computer-aided drug design (CADD) undoubtedly plays a key role in modern drug discovery. In recent years, this field has witnessed significant progress, mainly driven by the advancement of artificial intelligence (AI) algorithms in drug discovery programs. The growing availability of experimental data has promoted the development of highly accurate AI models with diverse applications such as predicting the pharmacological activity of molecules, ADME/Tox profiling and molecular properties’ prediction. Concurrently, increasing and more accessible computational power has further facilitated the use of conventional in silico drug discovery approaches, enabling the rapid screening of large chemical libraries.

On this ground, this Special Issues aims to present cutting-edge research that leverage computational methods to discover novel bioactive compounds, offering an overview of the current state of the art of this research field. Topics of this Special Issue include the development of new in silico approaches for drug discovery as well as the application of existing methodologies, such as molecular docking, molecular dynamics, pharmacophore modeling, homology modeling, QSAR and data-driven techniques, to drug design. Submissions may include original research or reviews in which CADD methods are developed and/or applied to identify new drugs candidates, optimize new hit compounds, perform structure–activity relationship studies, analyze ligand–target interactions and predict the ADME/Tox profile and the molecular properties of drug-like compounds.

Dr. Serena Vittorio
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. International Journal of Molecular Sciences is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. There is an Article Processing Charge (APC) for publication in this open access journal. For details about the APC please see here. Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • drug design
  • computational approaches
  • molecular docking
  • molecular dynamics
  • pharmacophore modeling
  • homology modeling
  • computer aided drug design
  • ADME/Tox predictions
  • artificial intelligence

Published Papers (1 paper)

Order results
Result details
Select all
Export citation of selected articles as:

Review

29 pages, 14051 KiB  
Review
The Structure–Antiproliferative Activity Relationship of Pyridine Derivatives
by Ana-Laura Villa-Reyna, Martin Perez-Velazquez, Mayra Lizett González-Félix, Juan-Carlos Gálvez-Ruiz, Dulce María Gonzalez-Mosquera, Dora Valencia, Manuel G. Ballesteros-Monreal, Milagros Aguilar-Martínez and Mario-Alberto Leyva-Peralta
Int. J. Mol. Sci. 2024, 25(14), 7640; https://doi.org/10.3390/ijms25147640 - 11 Jul 2024
Viewed by 418
Abstract
Pyridine, a compound with a heterocyclic structure, is a key player in medicinal chemistry and drug design. It is widely used as a framework for the design of biologically active molecules and is the second most common heterocycle in FDA-approved drugs. Pyridine is [...] Read more.
Pyridine, a compound with a heterocyclic structure, is a key player in medicinal chemistry and drug design. It is widely used as a framework for the design of biologically active molecules and is the second most common heterocycle in FDA-approved drugs. Pyridine is known for its diverse biological activity, including antituberculosis, antitumor, anticoagulant, antiviral, antimalarial, antileishmania, anti-inflammatory, anti-Alzheimer’s, antitrypanosomal, antimalarial, vasodilatory, antioxidant, antimicrobial, and antiproliferative effects. This review, spanning from 2022 to 2012, involved the meticulous identification of pyridine derivatives with antiproliferative activity, as indicated by their minimum inhibitory concentration values (IC50) against various cancerous cell lines. The aim was to determine the most favorable structural characteristics for their antiproliferative activity. Using computer programs, we constructed and calculated the molecular descriptors and analyzed the electrostatic potential maps of the selected pyridine derivatives. The study found that the presence and positions of the -OMe, -OH, -C=O, and NH2 groups in the pyridine derivatives enhanced their antiproliferative activity over the cancerous cellular lines studied. Conversely, pyridine derivatives with halogen atoms or bulky groups in their structures exhibited lower antiproliferative activity. Full article
Show Figures

Graphical abstract

Back to TopTop